In conclusion, our study provides compelling evidence that tumor-derived SAA suppresses anti-tumor immunity by impairing APC activation and antigen presentation via CD36, thus hindering CD8+ T cell-mediated cytotoxic responses. This evidence concerns the gene SAA1 and neoplasm.